Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:brain non-tumorous lesion incidence/prevalence measurement
go back to main search page
Accession:CMO:0000930 term browser browse the term
Definition:A measurement in which the number of individuals in a study population that display one or more non-tumorous lesion(s) of the brain at a point in time or develop such lesions within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. A non-tumorous lesion is a localized pathological change in structure of an organ or tissue due to injury or disease, which is not neoplastic in origin; especially one that is circumscribed and well defined. Examples of non-tumorous lesions of the brain would include infarctions, hemorrhages, etc.



show annotations for term's descendants           Sort by:

Term paths to the root